ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

NIH Carcinogen Guidelines Offered

April 24, 1981

Biomarker Identified Predicting Graft-Versus-Host Disease Risk

August 30, 2013

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993

OMB Proposal Would Slash NIH Budget $500 Million, NCI’s Reduction Could Be As Much As $125 Million

January 3, 1986

Also in this 8-page issue: White House appoints Koch Industries executive David Koch to the National Cancer Advisory Board. He asks: “How can we make the NCI elephant dance like a ballerina?”

September 17, 2004